Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucodentol vs Hydroxychloroquine for COVID-19 Prevention in Healthcare Providers
NCT04466280Withdrawn
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Aug 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, open-label trial of Mucodentol in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoint: PCR test result at 1 month. Planned start Aug 2020; status: withdrawn.
02
Drugs
Mucodentol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04466280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466280.